[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Pages 19592-19593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Sole Source Cooperative Agreement To Fund 
Rwanda Biomedical Center (RBC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $17,500,000, for Year 1 funding to RBC. The 
award will support a sustainable, affordable, integrated, and country-
led HIV/AIDS clinical and public health program in Rwanda. Funding 
amounts for years 2-5 will be set at continuation.

DATES: The period for this award will be September 30, 2024, through 
September 29, 2029.

FOR FURTHER INFORMATION CONTACT: Antyme Kayisabe, Center for Global 
Health, Centers for Disease Control and Prevention, 30 KG 7 Avenue 
(Kacyiru), P.O. Box 28 Kigali, Rwanda, telephone: 788382114, e-Mail: 
[email protected].

[[Page 19593]]


SUPPLEMENTARY INFORMATION: The sole source award will support the 
government of Rwanda's vision of achieving and maintaining HIV epidemic 
control and the UNAIDS goal of ending HIV/AIDS as a public health 
threat by 2030.
    RBC is in a unique position to conduct this work, as it possesses 
not only the mandate but also has the capacities to manage donor funds 
efficiently and in accordance with PEPFAR principles and United State 
Government regulations. All health workers implementing PEPFAR-
supported HIV clinical services including HIV testing, Antiretroviral 
Therapy, TB/HIV, prevention of mother to child transmission, and 
laboratory services are Ministry of Health (MOH) staff. All health 
facilities where PEPFAR-supported services are offered are under RBC 
accreditation and authorization. RBC is successfully coordinating HIV 
services in all health facilities countrywide. It is the only entity 
capable of providing comprehensive services and integrating HIV into 
the national health system to cover all Rwanda districts at each level.

Summary of the Award

    Recipient: Rwanda Biomedical Center (RBC).
    Purpose of the Award: The purpose of this award is to support a 
sustainable, affordable, integrated, and country-led HIV/AIDS clinical 
and public health program in Rwanda.
    Amount of Award: For RBC, the approximate year 1 funding amount 
will be $17,500,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003) (22 U.S.C. 7601, et seq.) and Public Law 110-293 (the Tom 
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and 
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013).
    Period of Performance: The period for this award will be September 
30, 2024, through September 29, 2029.

    Dated: March 13, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-05776 Filed 3-18-24; 8:45 am]
BILLING CODE 4163-18-P